Delivery Order SPE2DB22D1202-SPE2DB24FUVY1
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $2.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of dexamethasone 20 mg/5 ml vials. The $2,997.21 order is to be completed by January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide pharmaceutical products and medical supplies to DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Dexamethasone 20 mg/5 ml vials. The firm-fixed-price contract has a ceiling value of $1,491.26 and an ultimate completion date of August 30, 2024. This contract is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of the company's extensive federal contracting activities...
- This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,144.66, is for the supply of 4567759985 - Dexamethasone 10 mg/ml vial. The contract has an ultimate completion date of April 2, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,182.24, is for the delivery of 4,566,189,769 milliliters of dexamethasone 10 mg/mL vials. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.64 to AmerisourceBergen Drug Corp for the supply of Dexamethasone 20 mg/5 ml vials on a firm fixed price basis. The contract, awarded December 8, 2025, with completion targeted for December 9, 2025, represents a routine pharmaceutical procurement supporting federal medical supply chain operations. This award carries no set-aside designation, indicating it was competitively awarded through open competition. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,897.24 to AmerisourceBergen Drug Corp for Dexamethasone 10 mg/mL vials on November 6, 2025. This firm fixed-price contract, with a completion date of November 7, 2025, represents a non-set-aside, competitively awarded transaction for pharmaceutical supply supporting federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of dexamethasone 20 mg/5 ml vial, a critical pharmaceutical product. The $2,376.00 firm-fixed-price contract has a performance period through September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,803.88 firm fixed-price Delivery Order contract is for the supply of 4561770671 - Dexamethasone 20 mg/5 ml vial (5 ml), with an ultimate completion date of August 11, 2023. The award is a child contract under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,715.78, is for the delivery of dexamethasone 20 mg/5 ml vials with a final completion date of April 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, with the ID SPE2DB25D3404|SPE2DB25FUMRC, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dexamethasone 10 mg/ml vials, a critical medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,559.18 and a period of performance through March 26, 2025. It is not designated as a set-aside contract....